Most people seeking help with addiction spend weeks researching options before making a single call, and the quality of that decision shapes everything that follows. The best treatment for substance abuse isn’t a single program or method. It’s the right level of care, matched to your specific situation, delivered by a clinically sound team. This guide gives you the framework to evaluate your options clearly.

Why Treatment Type Determines Recovery Outcomes

According to SAMHSA’s 2023 National Survey on Drug Use and Health, only 6.3% of the 48.7 million Americans with a substance use disorder received any form of treatment in the past year. Of those who did seek help, outcomes varied dramatically based on the type and duration of care received, not simply the fact that they enrolled. NIDA’s research on treatment principles is direct on this point: programs that match the intensity of care to the severity of addiction produce measurably better long-term outcomes than those that don’t.

What this means in practice: the decision to seek help is necessary, but it’s not sufficient. Choosing the wrong level of care, such as entering a standard outpatient program when residential treatment is clinically indicated, produces lower completion rates and higher relapse risk. A 2022 analysis published in the Journal of Substance Abuse Treatment found that patients placed in level-appropriate care based on standardized criteria were 40% more likely to complete treatment than those who self-selected into lower-intensity programs. The type of treatment you choose is one of the most consequential decisions in the entire process.

The Main Types of Substance Abuse Treatment

The addiction treatment landscape runs a spectrum from medically supervised detox through residential care, partial hospitalization, intensive outpatient, and standard outpatient programs. Medication-assisted treatment (MAT) sits across multiple levels of this spectrum, as a tool available within several program types rather than a standalone setting. Understanding what distinguishes each level helps you evaluate options without being swayed by marketing language.

Medical Detox: The Necessary First Step for Many

For alcohol, opioid, and benzodiazepine dependence, medically supervised detox isn’t optional. It’s the only safe way to begin. Alcohol withdrawal can cause life-threatening seizures within 48 hours of the last drink. Benzodiazepine withdrawal carries similar risks. Opioid withdrawal, while rarely fatal, produces severe physiological distress that drives relapse before longer treatment even begins.

A 2021 study in the New England Journal of Medicine confirmed that unsupervised withdrawal from alcohol carries a mortality risk as high as 37% in severe cases without medical management. Medical detox provides 24-hour monitoring, medications to manage withdrawal symptoms, and a bridge into the next phase of treatment. The practical question to ask yourself: have you been drinking or using daily for more than a few weeks, or are you physically dependent on alcohol, benzos, or opioids? If yes, medical detox is the appropriate starting point before anything else.

Residential (Inpatient) Treatment

Residential treatment means living at the facility full-time, typically for 30 to 90 days. The structure matters as much as the duration: you’re removed from the environments, relationships, and stress triggers that fuel use, and replaced with a therapeutic routine that builds new patterns around the clock.

A 2023 study in Drug and Alcohol Dependence comparing residential and outpatient outcomes for individuals with severe opioid use disorder found that residential patients had a 35% higher rate of abstinence at 12 months. The clinical indicators that point toward residential are fairly clear: severe addiction, a home environment that doesn’t support sobriety, prior failed attempts at outpatient treatment, or co-occurring mental health conditions requiring intensive monitoring. If any of these apply to your situation, understanding what inpatient programs offer families and individuals is a necessary part of your research.

Outpatient Programs: PHP, IOP, and Standard Outpatient

Partial hospitalization programs (PHP) typically run 20 to 30 hours per week and serve people who need structured daily treatment but don’t require overnight care. PHPs are often used as a step-down from residential or as a primary level of care for people with a stable home environment and moderate-to-severe addiction.

Intensive outpatient programs (IOP) run roughly 9 to 15 hours per week across three to five days, combining group therapy, individual counseling, and psychoeducation. A 2022 meta-analysis in the Journal of Addiction Medicine found IOP outcomes comparable to residential treatment for individuals without severe psychiatric comorbidities or highly unstable living situations. Standard outpatient, at fewer than nine hours per week, is appropriate for mild addiction or as ongoing maintenance following a higher level of care.

The American Society of Addiction Medicine (ASAM) publishes standardized placement criteria that assess six dimensions: withdrawal potential, biomedical conditions, emotional or cognitive conditions, readiness to change, relapse potential, and recovery environment. A qualified clinician should walk through these dimensions with you to determine appropriate placement rather than letting program availability or cost drive the decision.

How to Match Treatment to the Substance

Treatment protocols differ significantly depending on which substance is involved, and a program designed for one population doesn’t automatically transfer to another. NIDA’s 13 principles of effective treatment include the explicit statement that no single treatment is appropriate for everyone, and that treatment must address the individual’s drug use alongside other medical, psychological, and social problems.

Opioid use disorder has the strongest evidence base for medication-assisted treatment, with buprenorphine, methadone, and naltrexone all showing significant reductions in overdose mortality. Alcohol use disorder responds to naltrexone and acamprosate. Stimulant use disorder, including methamphetamine and cocaine, has no FDA-approved medication as of 2024, making behavioral therapies the primary evidence-based approach. Poly-drug use requires programs equipped to address multiple dependencies simultaneously, which not all facilities are designed to do.

Before enrolling anywhere, ask directly: does your clinical protocol address the specific substance, and what does the evidence base look like for your approach to this population? A program that gives you a vague answer is telling you something important.

The Role of Medication-Assisted Treatment (MAT)

Stigma around MAT persists despite decades of contrary evidence. A landmark 2020 study published in NEJM Catalyst, drawing on data from over 40,000 patients, found that patients receiving buprenorphine or methadone for opioid use disorder were 50% less likely to die from overdose in the two years following treatment entry than those receiving no medication. MAT is not a substitute for sobriety. It’s a medical intervention that makes sustained recovery biologically possible for many people.

The three FDA-approved medications for opioid use disorder are methadone (dispensed through licensed opioid treatment programs), buprenorphine/naloxone (prescribable by certified providers in office-based settings), and injectable naltrexone (Vivitrol), which requires full detox before initiation. Naltrexone is also FDA-approved for alcohol use disorder, reducing craving and the rewarding effects of alcohol.

Here’s the practical move: if you’re evaluating a program for opioid or alcohol use disorder and their clinical team dismisses MAT outright, or refuses to discuss it as an option, treat that as a disqualifying red flag. Evidence-based care includes these medications when clinically indicated.

Dual Diagnosis: When Mental Health and Addiction Overlap

SAMHSA’s 2023 National Survey on Drug Use and Health found that 21.5 million adults in the United States had co-occurring substance use and mental health disorders. For this population, treating addiction in isolation produces significantly lower recovery rates. Depression, anxiety, PTSD, and bipolar disorder don’t pause during addiction treatment, and when they go unaddressed, they become primary drivers of relapse.

Integrated dual diagnosis treatment addresses both conditions simultaneously within the same clinical team, rather than referring out to separate providers. A 2021 study in Psychiatric Services found that patients receiving integrated dual diagnosis care had 25% higher treatment retention rates at six months compared to those in sequential or parallel programs.

The question to ask every program you evaluate: do you treat co-occurring mental health conditions on-site with licensed psychiatric staff, and is the treatment plan integrated or handled separately? If the answer is the latter, the two treatment tracks won’t inform each other, and outcomes suffer.

How to Evaluate a Treatment Program’s Quality

Accreditation is the floor, not the ceiling. Programs accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF) or The Joint Commission have met independently verified standards for clinical care, safety, and ethical operations. Accreditation doesn’t guarantee quality, but its absence is a warning sign worth taking seriously.

Beyond accreditation, look at the evidence base for the modalities being used. Cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing, and contingency management all have substantial research support for addiction treatment. A 2022 NIDA-funded review found programs using at least two evidence-based behavioral modalities alongside individualized treatment planning had significantly better 12-month abstinence outcomes than those relying on a single approach or unstructured group support. Treatment should be individualized: a single standardized program applied to every patient isn’t treatment, it’s processing.

Knowing what program features actually predict better outcomes before you tour facilities puts you in a much stronger position to evaluate what you’re being shown.

Questions to Ask Before You Enroll

The most important conversation you can have with any facility happens before you sign anything. Ask what the staff-to-client ratio is, and get a specific number. Ask whether your treatment plan will be individualized or based on a standardized curriculum. Ask how co-occurring mental health conditions are handled, who provides that care, and whether they’re licensed to do so on-site. Ask what the aftercare plan looks like at the point of discharge, and who manages that transition. Ask for the program’s accreditation status and the credentials of the clinical director.

These aren’t aggressive questions. They’re the baseline of informed consent. Any program that becomes evasive or pressures you to commit before answering them clearly deserves skepticism. For a more detailed breakdown of what to cover in that intake conversation, the right questions to ask a facility before enrolling provides a structured approach.

Red Flags in Treatment Programs

Predatory practices in addiction treatment are well-documented. The FTC and NIDA have both flagged patterns including unverifiable or exaggerated success rate claims, commission-based patient brokering, financial incentives for referrals, and programs that pressure families to commit to enrollment within hours of first contact. A legitimate program gives you time to make a careful decision.

Other warning signs: no licensed clinical staff on-site, no family involvement options during treatment, no structured aftercare planning, and programs that describe their approach in exclusively spiritual or experiential terms with no mention of evidence-based modalities. If the facility can’t produce accreditation documentation on request, walk away.

The Importance of Aftercare and Long-Term Support

Treatment doesn’t end at discharge. A 2022 study published in the Journal of Substance Abuse Treatment followed 1,200 patients post-discharge across multiple treatment settings and found that those enrolled in structured aftercare, including sober living, alumni programs, and outpatient step-down care, had a 46% lower relapse rate at 18 months than those who received no continuing care. Recovery is not a single event with a defined endpoint.

Structured aftercare includes outpatient step-down (transitioning from residential to PHP or IOP), sober living arrangements, peer support networks, and alumni programming. The best programs build aftercare into the treatment plan from day one, not as an afterthought at the end of the stay.

Before enrolling anywhere, ask one specific question: what does the discharge plan look like, and who manages the transition into aftercare? The answer tells you a great deal about how seriously the program takes long-term outcomes versus short-term completion metrics.

Family Involvement in the Treatment Decision

A 2021 study in the Journal of Substance Abuse Treatment analyzing outcomes across 3,800 patients found that family involvement in treatment planning was associated with a 28% improvement in treatment retention at 90 days. The mechanism is straightforward: people who feel supported by family are more likely to stay enrolled through the difficult early weeks of treatment.

For families researching options on behalf of someone they love, your role in the evaluation process is active, not passive. Attend intake consultations when possible. Participate in any family orientation or education sessions offered before enrollment. Ask the clinical team directly how family members are incorporated into the treatment plan, and what support or education is provided to the family system, not just the person in treatment.

What families need to understand when evaluating inpatient programs goes deeper into how to navigate this process when emotions are running high and decisions feel urgent.

Paying for Treatment: Insurance, Medicaid, and Other Options

The Mental Health Parity and Addiction Equity Act requires most insurance plans to cover substance use disorder treatment at parity with medical and surgical benefits. In practice, coverage varies by plan, and facilities vary in what they accept. The first step is calling your insurance provider to confirm whether a specific facility is in-network, what your deductible and out-of-pocket maximum are, and whether prior authorization is required for the level of care you need.

When you call a facility’s admissions team, ask whether they verify benefits on your behalf, what their billing practices are for out-of-network patients, and whether they offer financial assistance. For those without private insurance, California operates state-funded treatment programs through the Department of Health Care Services (DHCS), and Medi-Cal covers a broad range of substance use disorder services including residential treatment for eligible individuals. Sliding scale options exist at community-based programs throughout the Los Angeles area.

The specific action to take before making any facility decision: call your insurance provider with the facility’s name and NPI number and ask two questions: is this provider in-network for my plan, and what is my coverage for inpatient substance use disorder treatment?

Choosing Treatment in the Los Angeles Area

Los Angeles has one of the highest concentrations of addiction treatment facilities in the country, which creates a paradox: more options means more room for both excellent care and aggressive marketing. The density of programs in Southern California means that marketing budgets are large and claims are often unverifiable. A facility’s appearance, location, and amenities are not proxies for clinical quality.

What does matter for LA-based programs: proximity to family support in a region where family involvement improves outcomes, access to a strong sober community infrastructure (Los Angeles has one of the largest 12-step and peer recovery networks in the country), and whether the program is equipped to handle the specific population and substance use patterns prevalent in Southern California, including high rates of stimulant use disorder and poly-drug presentations.

California’s DHCS maintains a searchable database of licensed facilities. CARF and Joint Commission accreditation can be verified independently online. Narrow your list to three programs, schedule tours or intake calls within the same week, and evaluate each against the same criteria: accreditation, staff credentials, evidence-based modalities, dual diagnosis capacity, MAT access, and aftercare structure. A practical approach to comparing facilities side by side makes that process considerably faster.

What to Do This Week

Return to the SAMHSA statistic from the opening: of the nearly 49 million Americans with a substance use disorder last year, fewer than one in fifteen received treatment. The barrier is rarely motivation. It’s usually uncertainty about where to start.

Start with severity. Determine whether medical detox is the necessary first step based on your current level of physical dependence. If it is, that narrows your immediate options to programs with a licensed detox unit. Next, call your insurance provider today with one specific question: what is my coverage for inpatient substance use disorder treatment? That call takes fifteen minutes and eliminates significant uncertainty.

Then schedule one intake call with a program that meets the criteria in this guide: accredited, dual diagnosis capable, offering MAT access, with a clear aftercare plan. One call. This week. The quality of everything that follows depends on the quality of this first decision.